AustCancer Targeting Investors - Frankfurt Exchange Xetra Listing |
AustCancer Targeting European Investors through Frankfurt Exchange Xetra Listing
ASX/MEDIA RELEASE Sydney, Australia. The Board of the rapidly growing international biotechnology company, Australian Cancer Technology (“AustCancer” ASX:ACU) today announced that it has undertaken a secondary listing on the Xetra exchange, the electronic trading system of the Frankfurt Stock Exchange. AustCancer has contracted the Frankfurt based securities broker dealer firm, Seydler AG Securities and Financial Services, to act as Market Maker and Designated Sponsor for the company’s shares on Xetra. The Xetra listing is part of AustCancer’s strategy to broaden its international shareholder base. The company already has a Level 1 ADR program on NASDAQ (Code AUCJY) and plans to complete a small cap NASDAQ listing by the third quarter of the current financial year. The German listing is particularly significant, given AustCancer’s recently announced agreement with the German company RESprotect GmbH to acquire the North American licence to the highly promising developmental pancreatic cancer drug RP101. The code for AustCancer shares on Xetra is CBS and the German securities code (ISIN) is AU000000ACU7. Dr Roger Aston, AustCancer Chairman said, “AustCancer is now very much an international biotechnology company with business activities in the United States, Europe, Asia and Australia and we are keen to also grow our international shareholder base. The Xetra listing gives European investors, particularly those familiar with the German pancreatic drug technology we have recently acquired, the opportunity to participate in the growth opportunities we have available to us.” ENDS- PLEASE DIRECT ENQUIRIES TO:
Paul Hopper
Rene Parmantier
About Australian Cancer Technology
About Seydler AG
As one of the most renowned financial service providers in equity, derivative and bond trading, Seydler is a leading name in Germany’s most important financial centre – Frankfurt am Main. The firm offers an individual and high quality service to its clients, providing its expertise in capital markets to local and international institutional investors. www.seydler.de
|